Home > Insider Trading > Filing (0000903423-19-000327)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1706431	Vir Biotechnology Inc.	VIR	()	C0

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1362558	Authority Investment Dhabi Abu	211 Corniche Street Po Box 3600 Abu Dhabi C0	No	No	No	Yes
1790748	Ltd Rsc Holding Investment International Platinum	26Th Floor, Al Khatem Tower, Adgm Square Po Box 25642, Al Maryah Island Abu Dhabi C0 NA	No	No	No	Yes
1790749	Ltd Rsc 2018 B Falcon Platinum	26Th Floor, Al Khatem Tower, Adgm Square Po Box 25642, Al Maryah Island Abu Dhabi C0 NA	No	No	No	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-10-16	1,333,333	$0.00	1,333,333	No	4	C	Direct
Common Stock	Acquisiton	2019-10-16	1,333,333	$0.00	2,666,666	No	4	C	Direct
Common Stock	Acquisiton	2019-10-16	1,000,000	$20.00	3,666,666	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A-1 Preferred Stock	Disposition	2019-10-16	1,333,333	$0.00	1,333,333	$0.00
Common Stock	Series B Preferred Stock	Disposition	2019-10-16	1,333,333	$0.00	1,333,333	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
0			No	4	C	Direct

Footnotes

Upon closing of the issuer's initial public offering, the Series A-1 Preferred Stock and Series B Preferred Stock converted automatically into Common Stock on a 1-for-1 basis, without payment of further consideration. There was no expiration date for the Series A-1 Preferred Stock and Series B Preferred Stock. On September 27, 2019, prior to the closing of the issuer's initial public offering, the issuer effected a 1-for-4.5 reverse stock split of its Common Stock and Preferred Stock which is reflected in the numbers above.
Platinum Falcon B 2018 RSC Ltd. ("Platinum Falcon") directly holds the Common Stock. Platinum International Investment Holding RSC Limited ("Platinum Holdings") is the sole owner of Platinum Falcon, and the Abu Dhabi Investment Authority ("ADIA" and, together with Platinum Falcon and Platinum Holdings, the "Reporting Persons") is the sole owner of Platinum Holdings. Therefore, Platinum Holdings and ADIA may also be deemed to beneficially own the Common Stock. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.